4th Quarter - Report

VAN NESS FELDMAN, LLP for MCKESSON CORPORATION

A later version of this report replaces this one, so LegiList's totals use the current version instead. This page shows this version exactly as filed.

Firm
Client
Income
$60,000
Expenses
—

Versions of this report

Every filing the register holds for this firm, client and period, oldest first. The most recent one is the version LegiList counts.

Filing Filed Amount Counted
4th Quarter - Report (this page) Jan 20, 2016 $60,000 Replaced
4th Quarter - Amendment Mar 31, 2016 $60,000 Yes

What was lobbied

5 issue areas, each in the filer's own words, with who lobbied on it and where.

Taxation/Internal Revenue Code TAX

Proposals to repeal LIFO

LobbyistCovered position, as disclosed
NANCY MACAN MCNALLY —
JORDAN SMITH —

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Medicare/Medicaid MMM

Physician and pharmacy reimbursement issues and implementation of the Affordable Care Act

LobbyistCovered position, as disclosed
NANCY MACAN MCNALLY —
JORDAN SMITH —

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Veterans VET

Education regarding existing Department of Veterans' Affairs Pharmaceutical Prime Vendor contract

LobbyistCovered position, as disclosed
BEN LEE MCMAKIN —
NANCY MACAN MCNALLY —
JORDAN SMITH —

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Health Issues HCR

Incentives for health information technology, Affordable Care Act implementation, proposed regulation of medical software, proposals to promote healthcare interoperability, and other healthcare policy issues. H.R. 6, 21st Century Cures Act; H.R. 2396, SOFTWARE Act; S. 1101, MEDTECH Act; S. 2141, TRUST IT Act

LobbyistCovered position, as disclosed
NANCY MACAN MCNALLY —
JORDAN SMITH —

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Bills named: H.R. 2396 (114th), H.R. 6 (114th), S. 2141 (114th), S. 1101 (114th)

Pharmacy PHA

Pharmacy issues, prescription drug supply chain issues, drug shortages, prescription drug abuse and diversion, H.R. 471 "Ensuring Patient Access and Effective Drug Enforcement Act of 2015", S. 483 "Ensuring Patient Access and Effective Drug Enforcement Act of 2015"

LobbyistCovered position, as disclosed
NANCY MACAN MCNALLY —
JORDAN SMITH —

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Bills named: S. 483 (114th), H.R. 471 (114th)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.